Back

Secnidazole

Secnidazole is a long-acting nitroimidazole given as a single oral dose for bacterial vaginosis, trichomoniasis, giardiasis and amoebiasis. Its half-life of about 17 to 29 hours allows once-only dosing, which helps adherence.

Classification. Nitroimidazole.

Mechanism. The nitro group is reduced in anaerobic organisms, producing free radicals that break DNA; bactericidal and antiprotozoal.

Spectrum. Gardnerella and vaginal anaerobes, Trichomonas vaginalis, Entamoeba histolytica, Giardia lamblia and anaerobic bacteria. Helicobacter pylori resistance is common.

Pharmacokinetics. Well absorbed orally. Half-life 17 to 29 hours. Low protein binding. Hepatic metabolism with renal excretion.

Related

Clinical toolsCalculators

Latest content

Atlas’ Videos

From the newsroom

Atlas is one part of NiajeDoc.

Beyond the reference material, NDN Media Group produces explainers, interviews and health journalism for Kenyan audiences: the conversations that happen around the medicine, not just the protocols.

Explore NiajeDoc

Learn it.
Know it.
Own it.